A phase 1 trial has been completed in 30 months. Reports on various clinical trials for different diseases and conditions, including huntington's disease and idiopathic pulmonary fibrosis, are being released, with some trials showing potential. The specific outcomes and details of these trials are not consistent across reports, indicating uncertainty about the results.